Article
Interferon-gamma polymorphisms correlate with duration of survival in pancreatic cancer.
Human immunology - 1 Nov 2004
Halma M A T, Wheelhouse N M, Barber M D, Powell J J, Fearon K C H, Ross J A
Abstract excerpt
Despite progress in diagnosis and staging, pancreatic cancer still has a poor prognosis and it remains difficult to predict duration of survival in advanced pancreatic cancer. Nutritional decline, or cachexia, is a contributory factor to decreased survival in advanced pancreatic carcinoma, and it has been demonstrated that proinflammatory cytokines give rise to cachexia. Interferon (IFN)-gamma is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
